By Charles Bosquet
In a year marked by the continuing impact of the Covid-19 pandemic, the veterinary sector in France saw an intriguing contrast.
One area that witnessed significant growth was pain management for dogs and cats. The introduction of advanced treatments, particularly monoclonal antibodies, has contributed to a surge in sales, demonstrating the sector's ability to adapt and innovate in challenging times.
Two robust determinants that remained unchanging in 2022 were the increasing societal recognition of pets' importance and a steady growth in the pet population. This recognition has manifested in an increased medicalization of pets, with pet owners seeking more comprehensive and advanced healthcare for their furry companions.
A dip in pet registrations
Contrastingly, 2022 marked a decrease in pet registrations, with a decline of 10% compared to the previous year. This downturn followed two record years (2020 and 2021) for cat registrations, suggesting a possible saturation point or a delayed impact of the pandemic on pet ownership trends.
The Role of Kynetec’s PetTrak
|Clinic Attendance Change||Expenditure Change|
The year 2022 has proven to be one of contrasts and adaptations for the veterinary sector in France, with intriguing trends that will shape the future of pet care.